Chronic pancreatitis: what should be considered in diagnosis, treatment, and prognosis

T. N. Khristich, Yuriy Fedkovych Chernivtsi National University, Ukraine The aim of the literature review

Prognosismodifying therapy in patients with CAD: how to optimize treatment?

Authors: Khanyukov A.A., Professor, Doctor of Medical Sciences, Head of the Department of Internal Medicine,

Clinical case of acute pancreatitis associated with COVID -19 vaccination

Authors: N. B. Gubergrits (1), Yu. M. Alkhazov (2), N. A. Abdullaeva (3) (1) Into

Predictive-modifying therapy in patients with coronary artery disease (IHD): how to optimize treatment?

Diaphragmatic hernia: mechanisms of formation, clinic, treatment tactics

Experience of using pantoprazole in the complex therapy of diseases of the digestive tract of different age groups

Experience of using pantoprazole (Ulsepan) and a combined synbiotic (Opefera) in the complex therapy of children with gastroesophageal reflux disease and gastroduodenitis

Modern approaches to the treatment and prevention of gastrointestinal bleeding associated with NSAID gastropathy and stress ulcers

Ulsepan (pantoprazole) as an effective means of preventing erosive and ulcerative lesions of the gastroduodenal zone in patients during surgical interventions on the organs of the gastrointestinal tract

Drug prevention and treatment of gastropathies associated with the use of non-steroidal anti-inflammatory drugs

Selecting the Optimal Proton Pump Inhibitor for Patients with Coronary Artery Disease Who Require Dual Antiplatelet Therapy

Results of a multicenter study of the effectiveness of Helicobacter pylori eradication, carried out in accordance with the recommendations of the Maastricht Consensus V

The use of pantoprazole in the prevention of NSAID gastropathy

On the Ukrainian market, World Medicine presents the drug pantoprazole Ulsepan, which has proven its

ULSEPAN: pantoprazol 40 mg

The high efficacy of proton pump inhibitors (PPIs) makes this class of drugs one of